# A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

> **NCT06360094** · PHASE2 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 85 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis
- Progressive Pulmonary Fibrosis

## Interventions

- **DRUG:** BI 1839100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06360094
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-08-28
- **Primary completion:** 2025-09-02
- **Final completion:** 2025-09-02
- **Target enrollment:** 85 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360094, "A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06360094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*